Biography:

Hashim Ahmed Nur is a first year PhD student at the MRC toxicology unit in Cambridge under the supervision of Dr. Sarah Aitken. In his PhD, he is exploring the molecular and genomic responses to DNA damaging agents in the context of liver toxicity.   

Prior to commencing his PhD, he completed a master’s by research in cancer biology at Imperial College London where he carried out two distinct research projects:  

1. Characterising a novel PI3K pathway inhibitor in models of ovarian and pancreatic cancer models.   

2. Identifying methods to overcome multi-drug resistance in triple negative breast cancer.   

Research Interests:

Hashim’s research interests include drug development and how targeted therapies can be used to overcome chemotherapy resistance in the treatment of cancer.